Venture Challenge alumnus CC Diagnostics appoints new CEO

CC Diagnostics is proud to announce the appointment of Ronald Vos as the companies Chief Executive Officer. Ronald brings over 30 years of busi
Ronald Vos

Venture Challenge alumnus ATRO Medical initiates clinical trial

ATRO Medical has reached an important stage in tackling post-meniscectomy knee pain with the initiation of their clinical trial "AIR2" 
ATRO medical

Venture Challenge Winner Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings

Gosselies, Belgium and New York, N.Y.  - Ncardia forms strategic partnership with Kiniciti to build GMP capabilities to support iPSC cell therapy platforms and human cell-based in vitro discovery services

Venture Challenge alumnus MyLife Technologies raises €3.5 million to develop its vaccine delivery technology via ceramic vaccine patches for 'Pandemic Preparedness'

Leiden, – MyLife Technologies, which focuses on the development of ceramic vaccine patches for the simple, efficient and painless administration of vaccines through the skin, has raised €3.5 million from Fare Capital BV, SAL Beheer BV, informal inve
MyLife Technologies

Venture Challenge Winner SeraNovo Enters into License Agreement with Équilibre BioPharmaceuticals.

SeraNovo BV (Leiden, The Netherlands) is pleased to announce the closing of a License Agreement with Équilibre BioPharmaceuticals Corporation (New York, USA), a biopharmaceutical company engaged in the research and development of small molecules in
Seranovo Equilibre

Venture Challenge alumnus Scope Biosciences raises €1 Million funding from GenDx

WAGENINGEN - Diagnostic startup company Scope Biosciences B.V. has raised €1 Million funding from Utrecht based GenDx, specialized in Next Generation Sequencing (NGS) products for transplant diagnostics.
Scope Funding

Venture Challenge alumnus Praxa Sense initiates first clinical trial

Last month, Praxa Sense has started the first clinical trial with their Afi product at Reinier de Graaf ziekenhuis.
Praxa Sense

Venture Challenge alumnus BIMINI Biotech closes seed investment with Libertatis Ergo Holding

Leiden – BIMINI Biotech, an innovative therapeutics start-up that develops new cancer drugs, raised an investment of €250,000. The seed funding is provided by Libertatis Ergo Holding B.V.

Venture Challenge alumnus Mercurna reaches important scientific and IP milestones

Mercurna has reached its scientific and IP milestones of the RedMedtech Discovery Fund II (RMDFII) by providing exciting data (in vitro and in vivo) on mCura1, Mercurna’s lead formulation for chronic kidney disease.

Last chance to signup for the Paul Janssen Futurelab IP Course

The Paul Janssen Futurelab Intellectual Property Online course will start next Monday on October 11.
IP course